{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:58:23Z","timestamp":1771167503677,"version":"3.50.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ctrv.2012.11.005","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T21:31:35Z","timestamp":1356039095000},"page":"413-420","source":"Crossref","is-referenced-by-count":31,"title":["Thymoma and thymic carcinoma in the target therapies era"],"prefix":"10.1016","volume":"39","author":[{"given":"Angela","family":"Lamarca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2012.11.005_b0005","unstructured":"Available from: www.itmig.org\/. 2012"},{"key":"10.1016\/j.ctrv.2012.11.005_b0010","unstructured":"Available from: http:\/\/clinicaltrials.gov\/."},{"issue":"10 Suppl 4","key":"10.1016\/j.ctrv.2012.11.005_b0015","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1097-0142(197601)37:1<229::AID-CNCR2820370133>3.0.CO;2-2","article-title":"Thymoma: a clinical and pathological study of 65 cases","volume":"37","author":"Salyer","year":"1976","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0025","first-page":"162","article-title":"Human foamy virus genome in the thymus of myasthenia gravis patients","volume":"29","author":"Liu","year":"1996","journal-title":"Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi"},{"issue":"8898","key":"10.1016\/j.ctrv.2012.11.005_b0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(94)92657-3","article-title":"Human foamy virus infection in myasthenia gravis","volume":"343","author":"Saib","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ctrv.2012.11.005_b0035","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/path.1141","article-title":"Detection of Epstein\u2013Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization","volume":"197","author":"Chen","year":"2002","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00126334-200203010-00012","article-title":"Detection of HTLV-I tax-rex and pol gene sequences of thymus gland in a large group of patients with myasthenia gravis","volume":"29","author":"Manca","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0045","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","article-title":"Thymic carcinoma: state of the art review","volume":"59","author":"Eng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ctrv.2012.11.005_b0050","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO;2-D","article-title":"Thymoma. A clinicopathologic review","volume":"60","author":"Lewis","year":"1987","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.critrevonc.2007.04.005","article-title":"Management of thymomas","volume":"65","author":"Wright","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaad.2007.02.027","article-title":"Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease","volume":"57","author":"Wadhera","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"10 Suppl 4","key":"10.1016\/j.ctrv.2012.11.005_b0065","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1097\/JTO.0b013e3181f209a8","article-title":"Thymoma and thymic carcinoma: molecular pathology and targeted therapy","volume":"5","author":"Strobel","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1097-0142(196811)22:6<1221::AID-CNCR2820220619>3.0.CO;2-7","article-title":"Thymoma and cancer","volume":"22","author":"Souadjian","year":"1968","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.hoc.2008.03.011","article-title":"Imaging of thymic epithelial neoplasms","volume":"22","author":"Rosado-de-Christenson","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ejcts.2007.01.024","article-title":"Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology","volume":"31","author":"El Bawab","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.005_b0085","unstructured":"Tumours of the thymus, in Travis, WD, Brambilla, E, Muller-Hermelink, HK, Harris, CC. Pathology & Genetics: Tumours of the lung, pleura, thymus and heart. In: World Health Organization Classification of tumors. IARC Press, Lyon, 2004. 2011."},{"issue":"5","key":"10.1016\/j.ctrv.2012.11.005_b0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1309\/CYJH-9RXM-P2PK-120J","article-title":"On the histologic heterogeneity of thymic epithelial neoplasms. Impact of sampling in subtyping and classification of thymomas","volume":"114","author":"Moran","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/thx.48.6.632","article-title":"Percutaneous needle biopsy of the mediastinum: review of 94 procedures","volume":"48","author":"Morrissey","year":"1993","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1148\/radiology.180.1.1647039","article-title":"Anterior mediastinal masses: utility of transthoracic needle biopsy","volume":"180","author":"Herman","year":"1991","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2303.2012.01007.x","article-title":"Diagnosis and subclassification of thymoma by minimally invasive fine needle aspiration directed by endobronchial ultrasound: a review and discussion of four cases","volume":"23","author":"Moonim","year":"2012","journal-title":"Cytopathology"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0110","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histologic classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-200101000-00012","article-title":"Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors","volume":"25","author":"Okumura","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.ctrv.2012.11.005_b0120","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2012.11.005_b0125","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka\u2013Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/1010-7940(91)90210-B","article-title":"Seventeen years of surgical treatment of thymoma: factors influencing survival","volume":"5","author":"Gamondes","year":"1991","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-8140(94)01493-M","article-title":"Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer","volume":"34","author":"Cowen","year":"1995","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0140","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0003-4975(03)01017-8","article-title":"Lymphogenous and hematogenous metastasis of thymic epithelial tumors","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"10 Suppl. 4","key":"10.1016\/j.ctrv.2012.11.005_b0145","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2012.11.005_b0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/1010-7940(94)90155-4","article-title":"Thymectomy and malignancy","volume":"8","author":"Masaoka","year":"1994","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jso.1146","article-title":"Recurrence of thymoma: clinicopathological features, re-operation, and outcome","volume":"78","author":"Haniuda","year":"2001","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2012.11.005_b0160","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/1097-0142(19911101)68:9<1984::AID-CNCR2820680923>3.0.CO;2-P","article-title":"A tentative tumor-node-metastasis classification of thymoma","volume":"68","author":"Yamakawa","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2012.11.005_b0165","doi-asserted-by":"crossref","first-page":"S1698","DOI":"10.1097\/JTO.0b013e31821e7b12","article-title":"A review of prognostic factors in thymic malignancies","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0170","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0175","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5223(96)70265-9","article-title":"Prognostic factors and long-term results after thymoma resection: a series of 307 patients","volume":"112","author":"Regnard","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.ctrv.2012.11.005_b0180","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Strobel","year":"2004","journal-title":"J Clin Oncol"},{"issue":"10 Suppl 4","key":"10.1016\/j.ctrv.2012.11.005_b0185","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1097\/JTO.0b013e3181f20dab","article-title":"Evaluation and treatment of stage I and II thymoma","volume":"5","author":"Detterbeck","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0030-1271010","article-title":"Surgical resection of thymoma still represents the first choice of treatment","volume":"60","author":"Ried","year":"2012","journal-title":"Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0195","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1052-3359(25)00578-2","article-title":"Surgery for thymoma","volume":"11","author":"Port","year":"2001","journal-title":"Chest Surg Clin N Am"},{"key":"10.1016\/j.ctrv.2012.11.005_b0200","article-title":"Video-assisted thoracoscopic thymectomy (VAT-T) with lateral thoracotomy for stage II and III thymoma","author":"Hirai","year":"2012","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11748-011-0817-x","article-title":"First experience of robotic extended thymectomy in Japan for myasthenia gravis with thymoma","volume":"60","author":"Nakamura","year":"2012","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.athoracsur.2011.04.043","article-title":"Thoracoscopic thymectomy for myasthenia gravis with and without thymoma: a single-center experience","volume":"93","author":"Yu","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.005_b0215","unstructured":"Detterbeck FC, Parsons AD. Thymic tumors: a review of current diagnosis, classification, and treatment. In Thoracic and Esophageal surgery, 3rd Ed. Philadelphia, PA: Elsevier, 2008. Pp 1589\u20131614. 2008."},{"issue":"23","key":"10.1016\/j.ctrv.2012.11.005_b0220","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1002\/cncr.24618","article-title":"Postoperative radiation therapy after complete resection of thymoma has little impact on survival","volume":"115","author":"Utsumi","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0225","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0360-3016(99)00514-3","article-title":"Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study","volume":"46","author":"Myojin","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctrv.2012.11.005_b0230","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0003-4975(03)00819-1","article-title":"Comparison of stages I\u2013II thymoma treated by complete resection with or without adjuvant radiation","volume":"76","author":"Singhal","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"10 Suppl 4","key":"10.1016\/j.ctrv.2012.11.005_b0235","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1097\/JTO.0b013e3181f20ea2","article-title":"Technical advances of radiation therapy for thymic malignancies","volume":"5","author":"Gomez","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0360-3016(96)00086-7","article-title":"Entire hemithorax irradiation following complete resection in patients with stage II\u2013III invasive thymoma","volume":"35","author":"Uematsu","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0245","first-page":"31","article-title":"Treatment of invasive thymoma using low dose and extended-field irradiation including hemi-thorax or whole-thorax","volume":"46","author":"Kaseda","year":"1993","journal-title":"Kyobu Geka"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0250","first-page":"399","article-title":"The role of low-dose hemithoracic radiotherapy for thoracic dissemination of thymoma","volume":"15","author":"Yoshida","year":"1997","journal-title":"Radiat Med"},{"key":"10.1016\/j.ctrv.2012.11.005_b0255","doi-asserted-by":"crossref","first-page":"S1749","DOI":"10.1097\/JTO.0b013e31821ea5f7","article-title":"Chemotherapy: definitions and policies for thymic malignancies","volume":"6","author":"Girard","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0260","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","article-title":"Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma","volume":"68","author":"Macchiarini","year":"1991","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2012.11.005_b0265","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/oxfordjournals.annonc.a058527","article-title":"Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients","volume":"4","author":"Berruti","year":"1993","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0270","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","article-title":"Chemotherapy and operation for invasive thymoma","volume":"106","author":"Rea","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0275","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","article-title":"Long-term outcome after multimodality treatment for stage III thymic tumors","volume":"76","author":"Venuta","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2003.09.022","article-title":"Multimodal management of stages III\u2013IVa malignant thymoma","volume":"44","author":"Bretti","year":"2004","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0285","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0290","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.athoracsur.2004.12.047","article-title":"Advanced stage thymomas and thymic carcinomas: results of multimodality treatments","volume":"79","author":"Lucchi","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.coc.0000138963.01562.d3","article-title":"Multimodality treatment program in invasive thymic epithelial tumor","volume":"28","author":"Jacot","year":"2005","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/JTO.0b013e31802bafc8","article-title":"Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone","volume":"2","author":"Yokoi","year":"2007","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0305","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","article-title":"A phase II trial of dose\u2013dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh","year":"2010","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0310","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jtcvs.2007.07.049","article-title":"Feasibility of multimodality therapy including extended resections in stage IVA thymoma","volume":"134","author":"Huang","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.ctrv.2012.11.005_b0315","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2012.11.005_b0320","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6690773","article-title":"Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience","volume":"81","author":"Berruti","year":"1999","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.ctrv.2012.11.005_b0330","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00268-009-0069-4","article-title":"Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules","volume":"33","author":"Yano","year":"2009","journal-title":"World J Surg"},{"issue":"10 Suppl 4","key":"10.1016\/j.ctrv.2012.11.005_b0335","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1097\/JTO.0b013e3181f20e90","article-title":"Induction therapy for locally advanced thymoma","volume":"5","author":"Riely","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0340","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000421-199308000-00014","article-title":"EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma","volume":"16","author":"Bonomi","year":"1993","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2012.11.005_b0345","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1999.17.9.2737","article-title":"Treatment of invasive thymoma with single-agent ifosfamide","volume":"17","author":"Highley","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.005_b0350","doi-asserted-by":"crossref","unstructured":"(70) P.J.Loehrer SrCTYSDMBPHEGCaRPN. A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition).Vol 24, No 18S (June 20 Supplement), 2006: 7079.","DOI":"10.1200\/jco.2006.24.18_suppl.7079"},{"issue":"8","key":"10.1016\/j.ctrv.2012.11.005_b0355","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.1990.8.8.1419","article-title":"Chemotherapy of invasive thymoma","volume":"8","author":"Fornasiero","year":"1990","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0360","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2012.11.005_b0365","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2012.11.005_b0370","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.ctrv.2012.11.005_b0375","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4C","key":"10.1016\/j.ctrv.2012.11.005_b0380","first-page":"3005","article-title":"Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases","volume":"27","author":"Kanda","year":"2007","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0385","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/annonc\/mdp483","article-title":"Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)","volume":"21","author":"Palmieri","year":"2010","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0390","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0395","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0936-6555(05)80783-6","article-title":"Dramatic response of recurrent invasive thymoma to high doses of corticosteroids","volume":"4","author":"Kirkove","year":"1992","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0400","first-page":"67","article-title":"Rebound thymic hyperplasia following high dose chemotherapy and allogeneic BMT","volume":"11","author":"Miniero","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-5223(97)70399-4","article-title":"Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome","volume":"113","author":"Ruffini","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0410","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.semtcvs.2004.12.004","article-title":"Treatment of recurrent thymic tumors","volume":"17","author":"Ciccone","year":"2005","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0415","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0003-4975(97)01175-2","article-title":"Results of re-resection for recurrent thymomas","volume":"64","author":"Regnard","year":"1997","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0420","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/rg.262045213","article-title":"The thymus: a comprehensive review","volume":"26","author":"Nishino","year":"2006","journal-title":"Radiographics"},{"issue":"13","key":"10.1016\/j.ctrv.2012.11.005_b0425","first-page":"3708","article-title":"Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas","volume":"63","author":"Inoue","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ctrv.2012.11.005_b0430","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0002-9440(10)64426-4","article-title":"Chromosome 6 suffers frequent and multiple aberrations in thymoma","volume":"161","author":"Inoue","year":"2002","journal-title":"Am J Pathol"},{"issue":"10 Suppl 4","key":"10.1016\/j.ctrv.2012.11.005_b0435","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1097\/JTO.0b013e3181f21114","article-title":"Targeted therapy for advanced thymic tumors","volume":"5","author":"Rajan","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"10 Suppl 4","key":"10.1016\/j.ctrv.2012.11.005_b0440","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1097\/JTO.0b013e3181f209b9","article-title":"Thymic tumors: relevant molecular data in the clinic","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"36","key":"10.1016\/j.ctrv.2012.11.005_b0445","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"Kelly","year":"2011","journal-title":"J Clin Oncol"},{"issue":"33","key":"10.1016\/j.ctrv.2012.11.005_b0450","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1200\/JCO.2008.17.4284","volume":"26","author":"Heinrich","year":"2008","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.ctrv.2012.11.005_b0455","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ctrv.2012.11.005_b0460","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","article-title":"Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas","volume":"4","author":"Giaccone","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.005_b0465","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1200\/jco.2008.26.15_suppl.8116","article-title":"Imatinib for the treatment of thymic carcinoma","volume":"26","author":"Salter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0470","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/JTO.0b013e3181a52e25","article-title":"Long lasting response to the multikinase inhibitor bay 43\u20139006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma","volume":"4","author":"Bisagni","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"22","key":"10.1016\/j.ctrv.2012.11.005_b0475","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ctrv.2012.11.005_b0480","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jjco\/hyl028","article-title":"Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors","volume":"36","author":"Suzuki","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.005_b0485","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","article-title":"Cetuximab is an active treatment of metastatic and chemorefractory thymoma","volume":"12","author":"Palmieri","year":"2007","journal-title":"Front Biosci"},{"issue":"5","key":"10.1016\/j.ctrv.2012.11.005_b0490","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","article-title":"Response of thymoma to cetuximab","volume":"8","author":"Farina","year":"2007","journal-title":"Lancet Oncol"},{"issue":"Suppl","key":"10.1016\/j.ctrv.2012.11.005_b0495","article-title":"A phase II of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma","volume":"26","author":"Bedano","year":"2008","journal-title":"J Clin Oncol"},{"issue":"16 Suppl.","key":"10.1016\/j.ctrv.2012.11.005_b0500","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.ctrv.2012.11.005_b0505","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/cncr.25367","article-title":"Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas","volume":"116","author":"Zucali","year":"2010","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.ctrv.2012.11.005_b0510","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1158\/1078-0432.CCR-07-1118","article-title":"Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors","volume":"13","author":"Haluska","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2012.11.005_b0515","doi-asserted-by":"crossref","first-page":"e17525","DOI":"10.1200\/jco.2010.28.15_suppl.e17525","article-title":"Phase II study of the insulin-like growth factor-I receptor (IGF-1R) antibody cixutumumab (C) in patients (pts) with thymoma (T) and thymic carcinoma (TC)","volume":"28","author":"Rajan","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2012.11.005_b0520","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s005950170021","article-title":"Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surg Today"},{"key":"10.1016\/j.ctrv.2012.11.005_b0525","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.3599","article-title":"A phase I dose escalation and pharmacokinetic (PK) study of intravenous aflibercept (VEGF trap) plus docetaxel (D) in patients (pts) with advanced solid tumors: preliminary results","volume":"26","author":"Isambert","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0530","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Strobel","year":"2010","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.005_b0535","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/annonc\/mdq313","article-title":"Phase I trial of SU14813 in patients with advanced solid malignancies","volume":"22","author":"Fiedler","year":"2011","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2012.11.005_b0540","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.ctrv.2012.11.005_b0545","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1200\/jco.2009.27.15_suppl.7589","article-title":"Phase II study of the histone deacetylase inhibitor belinostat in thymic malignancies","volume":"27","author":"Giaccone","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.005_b0550","unstructured":"Wakelee HA, Burns M, Gubens M, et al. A phase II study of saracatinib (AZD0530), a SRC inhibitor, administered orally daily to patients (pts) with advanced thymic malignancies (ATM). [Abstract submitted for the ITMIG conference, New York, May, 2010]."}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573721200237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573721200237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:35:42Z","timestamp":1745937342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030573721200237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S030573721200237X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2012.11.005","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}